Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 EUR | -1.41% | -2.78% | -10.26% |
Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
Dec. 05 | Celyad Oncology CEO Resigns | MT |
Business Summary
Number of employees: 37
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michel Lussier
FOU | Founder | 67 | 07-07-23 |
David Georges
DFI | Director of Finance/CFO | - | 18-12-31 |
Eytan Breman
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
An Phan
LAW | General Counsel | 49 | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michel Lussier
FOU | Founder | 67 | 07-07-23 |
Hilde Windels
CHM | Chairman | 59 | 18-05-06 |
Serge Goblet
BRD | Director/Board Member | - | 07-12-31 |
Director/Board Member | 53 | 22-01-19 | |
Director/Board Member | - | - | |
Director/Board Member | 50 | 20-05-05 | |
Sage Mandel
BRD | Director/Board Member | - | - |
Marina Udier
BRD | Director/Board Member | - | 11-01-10 |
Ami Patel Shah
BRD | Director/Board Member | - | 21-12-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,428,572 | 38,267,083 ( 92.37 %) | 0 | 92.37 % |
Company contact information
Celyad Oncology SA
Axis Business Park rue Edouard Belin 2
1435, Mont-Saint-Guibert
+32 1 039 41 00
http://www.celyad.comSector
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.26% | 15.91M | |
+9.16% | 45.97B | |
+53.12% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock Celyad Oncology SA - Euronext Bruxelles
- Company Celyad Oncology SA